Revvity (RVTY) Cash from Financing Activities (2009 - 2026)
Revvity's (RVTY) quarterly Cash from Financing Activities came in at -$88.9 million in Q2 2026, up 45.68% YoY from -$61.0 million in Q2 2025, and up 49.58% on a QoQ basis from -$176.3 million in Q4 2025.
Revvity (RVTY) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Revvity (RVTY) has 18 years of Cash from Financing Activities data on file, last reported at -$88.9 million in Q2 2026.
- Quarterly Cash from Financing Activities rose 45.68% year-over-year to -$88.9 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$782.8 million (up 37.72% YoY) and the FY2025 annual result came in at -$857.5 million, up 23.99% from the prior year.
- Cash from Financing Activities grew to -$88.9 million in Q2 2026, from -$176.3 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of -$19.6 million in Q4 2023 to a low of -$3.7 billion in Q1 2023.
- A 5-year average of -$461.9 million and a median of -$176.3 million in 2025 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities soared 99.48% — and 2025, when it plunged 1041.63%.
- Tracing RVTY's Cash from Financing Activities over 5 years: stood at -$164.9 million in 2022, then jumped by 88.1% to -$19.6 million in 2023, then plunged by 883.94% to -$193.0 million in 2024, then grew by 8.64% to -$176.3 million in 2025, then soared by 49.58% to -$88.9 million in 2026.
- The last three Cash from Financing Activities figures came in at -$88.9 million (Q2 2026), -$176.3 million (Q4 2025), and -$215.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | -1.57 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 7.27 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -325.19 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -144.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -214.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -129.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -317.75 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -229.00 Mn |
| 10 | Revvity | 12.89 Bn | 12.03 Bn | 387.66 Mn | -88.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -88.90 Mn |
| Apr 5, 2026 | -88.90 Mn |
| Dec 28, 2025 | -176.31 Mn |
| Dec 28, 2025 | -176.31 Mn |
| Sep 28, 2025 | -215.07 Mn |
| Sep 28, 2025 | -215.07 Mn |
| Jun 29, 2025 | -302.48 Mn |
| Jun 29, 2025 | -302.48 Mn |
| Mar 30, 2025 | -163.66 Mn |
| Mar 30, 2025 | -163.66 Mn |
| Dec 29, 2024 | -192.99 Mn |
| Dec 29, 2024 | -192.99 Mn |
| Sep 29, 2024 | -873.74 Mn |
| Sep 29, 2024 | -873.74 Mn |
| Jun 30, 2024 | -26.50 Mn |
| Jun 30, 2024 | -26.50 Mn |
| Mar 31, 2024 | -35.01 Mn |
| Mar 31, 2024 | -35.01 Mn |
| Dec 31, 2023 | -19.61 Mn |
| Dec 31, 2023 | -19.61 Mn |